Karissa Johnston, Cal Shephard, Michael Friesen, Caitlin Azzalini, E. Penz
{"title":"加拿大布地奈德/甘草酸铵/富马酸福莫特罗二水合物三联疗法与双重疗法治疗慢性阻塞性肺病(COPD)的成本效益比较","authors":"Karissa Johnston, Cal Shephard, Michael Friesen, Caitlin Azzalini, E. Penz","doi":"10.1080/24745332.2023.2289890","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":9471,"journal":{"name":"Canadian Journal of Respiratory, Critical Care, and Sleep Medicine","volume":"30 23","pages":""},"PeriodicalIF":1.5000,"publicationDate":"2023-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cost-effectiveness of triple therapy with budesonide/glycopyrronium/formoterol fumarate dihydrate compared with dual therapy for the treatment of chronic obstructive pulmonary disease (COPD) in Canada\",\"authors\":\"Karissa Johnston, Cal Shephard, Michael Friesen, Caitlin Azzalini, E. Penz\",\"doi\":\"10.1080/24745332.2023.2289890\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":9471,\"journal\":{\"name\":\"Canadian Journal of Respiratory, Critical Care, and Sleep Medicine\",\"volume\":\"30 23\",\"pages\":\"\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2023-12-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Canadian Journal of Respiratory, Critical Care, and Sleep Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1080/24745332.2023.2289890\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"RESPIRATORY SYSTEM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian Journal of Respiratory, Critical Care, and Sleep Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/24745332.2023.2289890","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
Cost-effectiveness of triple therapy with budesonide/glycopyrronium/formoterol fumarate dihydrate compared with dual therapy for the treatment of chronic obstructive pulmonary disease (COPD) in Canada